Healthcare

Border Patrol Agents upset over new vaccine mandate

Published

2 years ago

October 1, 2021

[brid autoplay=”true” video=”845490″ player=”23886″ title=”Sara%20Carter%20calls%20Biden’s%20border%20policy%20a%20’disaster'” duration=”381″ description=”Fox News contributors Joe Concha and Sarah Carter and former acting ICE Director Tom Homan call Biden’s border policy a ‘disaster'” uploaddate=”2021-08-14″ thumbnailurl=”//cdn.brid.tv/live/partners/18168/thumb/845490_t_1628939970.png” contentUrl=”//cdn.brid.tv/live/partners/18168/sd/845490.mp4″]

A new COVID-19 vaccine mandate for Border Patrol agents requires them to receive the vaccine by Nov 1 or face termination. A whistleblower revealed the new policy. Carter reported on the story on Fox News’ Hannity.

But National Border Patrol Council President Chris Cabrera pointed out the hypocrisy of the mandate. Many of the migrants crossing the border don’t take COVID tests. “Agents are upset and rightfully so,” Cabrera told Carter. “We’re being required to take it. However people that are coming into the country illegally are already breaking one law and they’re getting preferential treatment.”

CRISIS ON THE BORDER: Biden’s open-border policies have created a major crisis on our southern border. @SaraCarterDC will report LIVE from the border and @LaraLeaTrump and @LaraLogan will react TONIGHT on “Hannity.”
— Sean Hannity (@seanhannity) October 1, 2021

Meanwhile, Department of Homeland Security Secretary Alejandro Mayorkas sets new policies that allow more migrants to stay in the states. “Morale has never been lower,” Carter said. She’s reported on border issues since 2004. “In fact, Border Patrol agents say with these new guidelines issued by DHS Secretary Mayorkas, they don’t even know what their job description is.”

“I think that’s just silly,” Cabrera said of Mayorkas’ policies. “You’re in the country illegally you’re subject to removal, that’s what the law says. For him to say otherwise, I don’t know if it’s wishful thinking on his part, if he doesn’t know what we do for a living. It’s ridiculous.”

Now, with these expectations that migrants can stay, border patrol agents anticipate bigger waves. “They’re saying as the weather starts to temper they’re going to expect more and more people,” Carter said. “They don’t have the resources, Sean, to handle this.”

Notably, between 50,000 and 85,000 people from Haiti alone are currently on their way to the border.

You can follow Jenny Goldsberry on Twitter @jennyjournalism.

China

FDA will work with China to import cancer drugs due to U.S. shortages

Published

2 days ago

June 7, 2023

Sara Carter Staff

Earlier this week the United States Food and Drug Administration (FDA) announced it will be working to import chemotherapy drugs from, of all places, China. The drug, called Cisplatin, is to help “ramp up supply amidst rampant drug shortages in the U.S.” reports Foreign Desk News.

Foreign Desk News writes:

Cisplatin comes from drugmaker Qilu Pharmaceutical, which is marketed and produced in China but has not been approved by the FDA. According to a May 24 letter, Qilu will work with the Canadian-based drug company Apotex to import and distribute the medication, which will come in 50-milligram vials with Chinese labels.

“The FDA is responding to yet another generic drug shortage,” said Edmund F. Haislmaier, an expert in healthcare policy and markets at The Heritage Foundation. “The underlying cause of those shortages is that generic drugs have become low-margin commodity products,” he added.

Last week on Twitter, FDA commissioner Dr. Robert Califf said the partnership with Qilu Pharmaceutical is temporary but will provide patients with a potentially life-extending drug.

“The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages,” Califf said.

The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages. https://t.co/8XvOuJzSL4

— Dr. Robert M. Califf (@DrCaliff_FDA) June 3, 2023

Foreign Desk News adds:

The latest move by the FDA is sure to spark concern and debate in Congress, as lawmakers in the House and Senate have called on the Biden administration to de-couple the U.S. economy from the Chinese markets, given Beijing’s aggressive push to expand in the South-China Sea and eventually take over the island state of Taiwan. China has also spread illegal and dangerous synthetic opioids and fentanyl drugs across the U.S. southern border, resulting in the devastating deaths of many Americans.